1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Rise in Expenditure

        4.1.2. Increased Per Capita Expenditure

    4.2. Forecast Factors – Relevance & Impact

        4.2.1. Product in Pipeline

        4.2.2. Regulatory Scenario

        4.2.3. Mergers and Acquisitions

        4.2.4. Collaborative Agreements

        4.2.5. Value Chain

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

    4.4. COVID19 Crisis Analysis

        4.4.1. Current COVID19 Statistics and Probable Future Impact

        4.4.2. Current GDP Projection and Probable Impact

        4.4.3. Current Economic Projection as Compared to 2008 Economic analysis

        4.4.4. COVID19 and Impact Analysis

            4.4.4.1. Revenue By Therapy

            4.4.4.2. Revenue By Cancer Type

            4.4.4.3. Revenue By Mode of Administration

            4.4.4.4. Revenue By Animal Type

            4.4.4.5. Revenue By Distribution Channel

            4.4.4.6. Revenue By Country

        4.4.5. 2020 Market Scenario

        4.4.6. Quarter by Quarter Forecast

        4.4.7. Projected Recovery Quarter

        4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact

5. Market Context

    5.1. Adoption and Usage Analysis

    5.2. Market Evolution

    5.3. Product Vs Cancer Type Matrix

    5.4. Regulatory Scenario

    5.5. Parent Market Analysis

    5.6. Key Promotional Strategies by Market Players

6. Global Market – Pricing Analysis

    6.1. Regional Pricing Analysis By Therapy

    6.2. Pricing Break-up

        6.2.1. Manufacturer Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. Global Average Pricing Analysis Benchmark

7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033

    7.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022

    7.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapy

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Therapy, 2018 to 2022

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy, 2023 to 2033

        8.3.1. Radiology

        8.3.2. Chemotherapy

        8.3.3. Combination Therapy

        8.3.4. Immunotherapy

        8.3.5. Targeted Therapy

    8.4. Market Attractiveness Analysis By Therapy

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Mode of Administration

    9.1. Introduction / Key Findings Nature Size, 2018 to 2022

    9.2. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode of Administration, 2023 to 2033

        9.2.1. Oral

        9.2.2. Intravenous

    9.3. Market Attractiveness Analysis By Mode of Administration

10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Cancer Type

    10.1. Introduction / Key Findings Cancer Type Size, 2018 to 2022

    10.2. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cancer Type, 2023 to 2033

        10.2.1. Lymphoma

        10.2.2. Mast Cells

        10.2.3. Mammary & Squamous Cells

    10.3. Market Attractiveness Analysis By Cancer Type

11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Animal Type

    11.1. Introduction / Key Findings Size, 2018 to 2022

    11.2. Current and Future Market Size (US$ Mn) Analysis and Forecast By Animal Type, 2023 to 2033

        11.2.1. Canine

        11.2.2. Feline

    11.3. Market Attractiveness Analysis By Animal Type

12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2018 to 2022

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023 to 2033

        12.3.1. Hospital Pharmacies

        12.3.2. Government Agencies

        12.3.3. Retail Pharmacies

    12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 to 2022

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. United States

            14.3.1.2. Canada

        14.3.2. By Therapy

        14.3.3. By Nature

        14.3.4. By Cancer Type

        14.3.5. By Animal Type

        14.3.6. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Market Trends

    14.6. Key Market Participants – Intensity Mapping

    14.7. Drivers and Restraints – Impact Analysis

15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. United Kingdom

            15.3.1.5. Spain

            15.3.1.6. Rest of Europe

        15.3.2. By Therapy

        15.3.3. By Nature

        15.3.4. By Cancer Type

        15.3.5. By Animal Type

        15.3.6. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Market Trends

    15.6. Key Market Participants – Intensity Mapping

    15.7. Drivers and Restraints – Impact Analysis

16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. GCC Countries

            16.3.1.2. South Africa

            16.3.1.3. Rest of Middle East and Africa

        16.3.2. By Therapy

        16.3.3. By Nature

        16.3.4. By Cancer Type

        16.3.5. By Animal Type

        16.3.6. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Market Trends

    16.6. Key Market Participants – Intensity Mapping

    16.7. Drivers and Restraints – Impact Analysis

17. Rest of the World Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Therapy

        17.3.2. By Mode of Administration

        17.3.3. By Cancer Type

        17.3.4. By Animal Type

        17.3.5. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Market Trends

    17.6. Key Market Participants – Intensity Mapping

    17.7. Drivers and Restraints – Impact Analysis

18. Key and Emerging Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. United States Market Analysis

        18.2.1. By Therapy

        18.2.2. By Mode of Administration

        18.2.3. By Cancer Type

        18.2.4. By Animal Type

        18.2.5. By Distribution Channel

    18.3. Canada Market Analysis

        18.3.1. By Therapy

        18.3.2. By Mode of Administration

        18.3.3. By Cancer Type

        18.3.4. By Animal Type

        18.3.5. By Distribution Channel

    18.4. United Kingdom Market Analysis

        18.4.1. By Therapy

        18.4.2. By Mode of Administration

        18.4.3. By Cancer Type

        18.4.4. By Animal Type

        18.4.5. By Distribution Channel

    18.5. Germany Market Analysis

        18.5.1. By Therapy

        18.5.2. By Mode of Administration

        18.5.3. By Cancer Type

        18.5.4. By Animal Type

        18.5.5. By Distribution Channel

    18.6. France Market Analysis

        18.6.1. By Therapy

        18.6.2. By Mode of Administration

        18.6.3. By Cancer Type

        18.6.4. By Animal Type

        18.6.5. By Distribution Channel

    18.7. Italy Market Analysis

        18.7.1. By Therapy

        18.7.2. By Mode of Administration

        18.7.3. By Cancer Type

        18.7.4. By Animal Type

        18.7.5. By Distribution Channel

    18.8. Spain Market Analysis

        18.8.1. By Therapy

        18.8.2. By Mode of Administration

        18.8.3. By Cancer Type

        18.8.4. By Animal Type

        18.8.5. By Distribution Channel

        18.8.6. By Distribution Channel

    18.9. GCC Countries Market Analysis

        18.9.1. By Therapy

        18.9.2. By Mode of Administration

        18.9.3. By Cancer Type

        18.9.4. By Animal Type

        18.9.5. By Distribution Channel

    18.10.  South Africa Market Analysis

        18.10.1. By Therapy

        18.10.2. By Mode of Administration

        18.10.3. By Cancer Type

        18.10.4. By Animal Type

        18.10.5. By Distribution Channel

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product foot print by Players

        19.4.3. Channel Foot Print by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. Elanco

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Analyst Commentary

            20.3.1.4. Key Financials

            20.3.1.5. Recent Developments

            20.3.1.6. Sales Footprint

            20.3.1.7. Strategy Overview

                20.3.1.7.1. Marketing Strategy

                20.3.1.7.2. Product Strategy

                20.3.1.7.3. Channel Strategy

        20.3.2. Morphogenesis

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Analyst Commentary

            20.3.2.4. Key Financials

            20.3.2.5. Recent Developments

            20.3.2.6. Sales Footprint

            20.3.2.7. Strategy Overview

                20.3.2.7.1. Marketing Strategy

                20.3.2.7.2. Product Strategy

                20.3.2.7.3. Channel Strategy

        20.3.3. Accuray Incorporated

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Analyst Commentary

            20.3.3.4. Key Financials

            20.3.3.5. Recent Developments

            20.3.3.6. Sales Footprint

            20.3.3.7. Strategy Overview

                20.3.3.7.1. Marketing Strategy

                20.3.3.7.2. Product Strategy

                20.3.3.7.3. Channel Strategy

        20.3.4. Regeneus Ltd.

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Analyst Commentary

            20.3.4.4. Key Financials

            20.3.4.5. Recent Developments

            20.3.4.6. Sales Footprint

            20.3.4.7. Strategy Overview

                20.3.4.7.1. Marketing Strategy

                20.3.4.7.2. Product Strategy

                20.3.4.7.3. Channel Strategy

        20.3.5. PetCure Oncology

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Analyst Commentary

            20.3.5.4. Key Financials

            20.3.5.5. Recent Developments

            20.3.5.6. Sales Footprint

            20.3.5.7. Strategy Overview

                20.3.5.7.1. Marketing Strategy

                20.3.5.7.2. Product Strategy

                20.3.5.7.3. Channel Strategy

        20.3.6. Zoetis

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Analyst Commentary

            20.3.6.4. Key Financials

            20.3.6.5. Recent Developments

            20.3.6.6. Sales Footprint

            20.3.6.7. Strategy Overview

                20.3.6.7.1. Marketing Strategy

                20.3.6.7.2. Product Strategy

                20.3.6.7.3. Channel Strategy

        20.3.7. Karyopharm

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Analyst Commentary

            20.3.7.4. Key Financials

            20.3.7.5. Recent Developments

            20.3.7.6. Sales Footprint

            20.3.7.7. Strategy Overview

                20.3.7.7.1. Marketing Strategy

                20.3.7.7.2. Product Strategy

                20.3.7.7.3. Channel Strategy

        20.3.8. Varian Medical Systems, Inc.

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Analyst Commentary

            20.3.8.4. Key Financials

            20.3.8.5. Recent Developments

            20.3.8.6. Sales Footprint

            20.3.8.7. Strategy Overview

                20.3.8.7.1. Marketing Strategy

                20.3.8.7.2. Product Strategy

                20.3.8.7.3. Channel Strategy

        20.3.9. OHC (One Health Company)

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Analyst Commentary

            20.3.9.4. Key Financials

            20.3.9.5. Recent Developments

            20.3.9.6. Sales Footprint

            20.3.9.7. Strategy Overview

                20.3.9.7.1. Marketing Strategy

                20.3.9.7.2. Product Strategy

                20.3.9.7.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

※参考情報 動物における腫瘍は、特に獣医療において重要な研究領域であり、さまざまな種類の癌や良性腫瘍を含みます。腫瘍は、体内の細胞が異常に増殖することにより形成されます。腫瘍は通常、悪性と良性に分類されます。悪性腫瘍は周囲の組織に浸潤し、転移する可能性があります。一方、良性腫瘍は通常、周囲の組織を圧迫することはあっても、浸潤や転移のリスクはほとんどありません。 獣医腫瘍学では、主に犬や猫を対象に腫瘍の診断、治療、予防について研究されています。特に犬と猫は人間と同じようにさまざまな腫瘍にかかることがあり、それぞれに適した治療法が必要となります。代表的な悪性腫瘍には、リンパ腫、乳腺腫瘍、骨肉腫、腺癌などがあります。 リンパ腫は犬や猫でよく見られる悪性腫瘍で、リンパ系に由来しています。飼い主による早期発見が重要で、治療方法には化学療法や放射線治療が用いられます。乳腺腫瘍は特に雌犬や雌猫に多く見られ、ホルモンの影響が大きいとされています。早期に手術を行うことで、予後が改善されることが多いです。 骨肉腫は大型犬に多い悪性腫瘍で、骨に発生します。外科的切除が行われることが一般的で、その後の化学療法や放射線治療も選択肢として考えられます。腺癌や皮膚腫瘍も一般的で、これらも早期の発見と治療が鍵を握ります。 腫瘍の診断にはいくつかの手法が用いられます。生検と呼ばれる検査や画像診断（X線、CTスキャン、MRIなど）を通じて、腫瘍の性質や広がりを確認し、その結果に基づいて治療計画が立てられます。獣医師は、腫瘍の種類や発生場所に応じた最適な治療法を選択する必要があります。 治療法には、手術、化学療法、放射線治療、免疫療法などがあります。それぞれの治療法には利点と欠点があり、獣医師は患者の健康状態や腫瘍の進行状況に基づいて選択を行います。手術は腫瘍を物理的に切除する方法であり、成功率が高いですが、周囲の組織への影響や麻酔リスクを考慮する必要があります。 化学療法は、抗がん剤を用いた治療法で、悪性腫瘍の治療に広く用いられています。副作用が生じる可能性があるため、動物の体調をモニタリングしながら治療を進めることが大切です。放射線治療は、腫瘍細胞を破壊するために高エネルギーの放射線を使用します。局所的な腫瘍に対して効果的ですが、周囲の正常組織にも影響を与える可能性があるため、慎重に行われるべきです。 近年では、免疫療法も注目されており、体の免疫系を利用して腫瘍に対抗させる方法です。自己免疫力を強化することで、腫瘍細胞を攻撃するというアプローチが研究されています。これにより、副作用を最小限に抑えつつ、効果的に腫瘍を抑え込むことが期待されています。 動物における腫瘍研究は急速に進化しており、新しい治療法や技術が次々と開発されています。動物の腫瘍を早期に発見し、適切に管理するためには、定期的な健康診断と飼い主の注意が不可欠です。獣医腫瘍学は、動物の生命を延ばすだけでなく、治療の質を向上させ、動物のQOL（生活の質）を重視した研究が進められています。腫瘍に関する知識を深めることは、飼い主、獣医師双方にとって大切なことであり、今後も更なる研究と情報提供が期待されます。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/